These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 31624459

  • 1. Rapid serum tube technology overcomes problems associated with use of anticoagulants.
    Zhao KN, Dimeski G, de Jersey J, Johnson LA, Grant M, Masci PP, Lavin MF.
    Biochem Med (Zagreb); 2019 Oct 15; 29(3):030706. PubMed ID: 31624459
    [Abstract] [Full Text] [Related]

  • 2. Next-generation rapid serum tube technology using prothrombin activator coagulant: fast, high-quality serum from normal samples.
    Zhao KN, Dimeski G, de Jersey J, Johnson LA, Grant M, Masci PP, Lavin MF.
    Clin Chem Lab Med; 2019 Mar 26; 57(4):483-497. PubMed ID: 30267622
    [Abstract] [Full Text] [Related]

  • 3. Potential Application of Recombinant Snake Prothrombin Activator Ecarin in Blood Diagnostics.
    Zhao KN, Masci P, Dimeski G, Johnson L, Grant M, de Jersey J, Lavin MF.
    Biomolecules; 2022 Nov 17; 12(11):. PubMed ID: 36421717
    [Abstract] [Full Text] [Related]

  • 4. Generation of Rapid and High-Quality Serum by Recombinant Prothrombin Activator Ecarin (RAPClot™).
    Zhao KN, Dimeski G, Masci P, Johnson L, Wang J, de Jersey J, Grant M, Lavin MF.
    Biomolecules; 2024 May 30; 14(6):. PubMed ID: 38927049
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of the Greiner Bio-One serum separator BCA Fast Clot tube.
    Dimeski G, Johnston J, Masci PP, Zhao KN, Brown N.
    Clin Chem Lab Med; 2017 Jul 26; 55(8):1135-1141. PubMed ID: 28076307
    [Abstract] [Full Text] [Related]

  • 6. Heparin supplement counteracts the prohemostatic effect of prothrombin complex concentrate and factor IX concentrate: An in vitro evaluation.
    Brinkman HJ, Patiwael S, Tripathi S, Meijers JC.
    Thromb Res; 2016 Mar 26; 139():102-10. PubMed ID: 26916304
    [Abstract] [Full Text] [Related]

  • 7. Rivaroxaban and dabigatran did not affect clotting profiles in plasma reconstituted with varying levels of autologous platelets to the same degree as heparin when evaluated using thromboelastography.
    Gantioqui J, Stevic I, Atkinson H, Chan AKC.
    Blood Coagul Fibrinolysis; 2018 Sep 26; 29(6):521-527. PubMed ID: 29965810
    [Abstract] [Full Text] [Related]

  • 8. Different Heparin Contents in Prothrombin Complex Concentrates May Impair Blood Clotting in Outpatients With Ventricular Assist Devices Receiving Phenprocoumon.
    Felli A, Zeidler P, Jilma B, Opfermann P, Holaubek C, Zimpfer D, Wadowski PP, Steinlechner B.
    J Cardiothorac Vasc Anesth; 2016 Jan 26; 30(1):96-101. PubMed ID: 26613641
    [Abstract] [Full Text] [Related]

  • 9. Endogenous thrombin potential as a novel method for the characterization of procoagulant snake venoms and the efficacy of antivenom.
    Isbister GK, Woods D, Alley S, O'Leary MA, Seldon M, Lincz LF.
    Toxicon; 2010 Aug 01; 56(1):75-85. PubMed ID: 20338189
    [Abstract] [Full Text] [Related]

  • 10. Effects of S-hexyl-L-cysteine derivatives on prothrombin activation and clotting time determined in the presence of heparin.
    Midura-Nowaczek K, Bruzgo I, Krajewska D.
    Adv Med Sci; 2009 Aug 01; 54(1):47-50. PubMed ID: 19648086
    [Abstract] [Full Text] [Related]

  • 11. Rapid point-of-care assay of enoxaparin anticoagulant efficacy in whole blood.
    Inchiosa MA, Pothula S, Kubal K, Sanchala VT, Navarro I.
    J Vis Exp; 2012 Oct 12; (68):. PubMed ID: 23093300
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic uses of snake venom.
    Marsh NA.
    Haemostasis; 2001 Oct 12; 31(3-6):211-7. PubMed ID: 11910187
    [Abstract] [Full Text] [Related]

  • 13. Monitoring of recombinant hirudin: assessment of a plasma-based ecarin clotting time assay.
    Pötzsch B, Hund S, Madlener K, Unkrig C, Müller-Berghaus G.
    Thromb Res; 1997 Jun 01; 86(5):373-83. PubMed ID: 9211628
    [Abstract] [Full Text] [Related]

  • 14. Aprotinin prolongs activated and nonactivated whole blood clotting time and potentiates the effect of heparin in vitro.
    Despotis GJ, Filos KS, Levine V, Alsoufiev A, Spitznagel E.
    Anesth Analg; 1996 Jun 01; 82(6):1126-31. PubMed ID: 8638779
    [Abstract] [Full Text] [Related]

  • 15. Thrombin generation assay and viscoelastic coagulation monitors demonstrate differences in the mode of thrombin inhibition between unfractionated heparin and bivalirudin.
    Tanaka KA, Szlam F, Sun HY, Taketomi T, Levy JH.
    Anesth Analg; 2007 Oct 01; 105(4):933-9, table of contents. PubMed ID: 17898368
    [Abstract] [Full Text] [Related]

  • 16. Lupus anticoagulant testing with optical end point automation.
    Luddington R, Scales C, Baglin T.
    Thromb Res; 1999 Nov 01; 96(3):197-203. PubMed ID: 10588462
    [Abstract] [Full Text] [Related]

  • 17. Use of different anticoagulants in test tubes for analysis of blood lactate concentrations: Part 2. Implications for the proper handling of blood specimens obtained from critically ill patients.
    Wiese J, Didwania A, Kerzner R, Chernow B.
    Crit Care Med; 1997 Nov 01; 25(11):1847-50. PubMed ID: 9366768
    [Abstract] [Full Text] [Related]

  • 18. Practical applications of snake venom toxins in haemostasis.
    Marsh N, Williams V.
    Toxicon; 2005 Jun 15; 45(8):1171-81. PubMed ID: 15922782
    [Abstract] [Full Text] [Related]

  • 19. [Effects of aprotinin on heparinized whole blood activated clotting time and whole blood prothrombin time].
    Wen Z, Zhu F, He X, Xiong S, He S.
    Hunan Yi Ke Da Xue Xue Bao; 1997 Jun 15; 22(4):304-6. PubMed ID: 9868081
    [Abstract] [Full Text] [Related]

  • 20. Assessing Coagulation by Rotational Thromboelastometry (ROTEM) in Rivaroxaban-Anticoagulated Blood Using Hemostatic Agents.
    Bar J, David A, Khader T, Mulcare M, Tedeschi C.
    Prehosp Disaster Med; 2017 Oct 15; 32(5):580-587. PubMed ID: 28625215
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.